This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
CME
Watch CME-accredited learning activities in collaboration with the EACIC
Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 1 CME credit...
An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 1 CME credit...
The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
This interview was supported by an independent educational grant by Bial CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 0.5 CME credit...
Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
An exclusive 1:1 interview, featuring industry leading expert; Dr. Monica Kurtis, MD: Movement Disorders Program, Neurology Department - Hospital Ruber Internacional,...
Patient-Centric Management for General Neurologists – Advanced Parkinson’s Disease
An exclusive panel discussion, featuring the following industry leading experts: Bas Bloem, MD, PhD, Wolfgang Oertel, MD, PhD, Andrew Evans, MD & Zvezdan Pirtošek,...
‘Wearing off’ to L-DOPA and its underlying mechanisms
An exclusive 1:1 interview, featuring industry leading expert; Prof. Peter Jenner, Emeritus Professor of Pharmacology, King’s College London, UK This interview was...
Multidisciplinary care in PD – Does it make a difference?
An exclusive duo interview, featuring the following industry leading experts: Professor Werner Poewe, & Professor Bas Bloem. This duo interview was supported by an...
Parkinson’s Disease – Patient Roleplay
An exclusive patient roleplay, featuring the following industry leading expert: Donald Grosset BSc Hons & Parkinson's Disease patient, John Sterling. CME...
Optimising ON Time – Advanced Parkinson’s Disease
An exclusive panel discussion, featuring the following industry leading experts: Donald Grosset BSc Hons, MBChB, MD; Fabrizio Stocchi MD, PhD & Joaquim Ferreira MD,...
Motor Symptoms and Therapy Choices – Advanced Parkinson’s Disease
An exclusive panel discussion, featuring the following industry leading experts: Bas Bloem, MD, PhD; Per Odin MD, PhD & Olivier Rascol, MD, PhD CME ACCREDITED - The...
Tailoring Levodopa according to patient characteristics
An exclusive duo interview, featuring the following industry leading experts: Professor Werner Poewe, & Professor Bas Bloem.
Living with Parkinson’s – The Impact of Treatment Choices
An exclusive panel discussion, featuring the following industry leading experts: Werner Poewe, MD, PhD; Angelo Antonini MD, PhD & Pablo Mir, MD, PhD CME ACCREDITED...
Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
An exclusive 3 part 1:1 interview, featuring industry leading expert; Professor Fabrizio Stocchi Part 1 A knowledge of the COMT mechanism of action in humans and the...
An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence
An exclusive 2 part webinar, featuring the following industry leading experts: Peter Rothwell, MD, PhD Jens Erik Nielsen-Kudsk, MD, PhD Hans-Christoph Diener, MD, PhD...
Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
An exclusive one to one interview with Professor Per Odin, Head of Office, Neurology, Lund University, Sweden This interview was supported by an independent educational...
A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
An exclusive panel discussion, featuring the following industry leading experts: Werner Poewe, Per Odin & Angelo Antonini This roundtable discussion was supported...
The impact of COVID-19 for families with Parkinson’s Disease
An exclusive one to one interview with Professor Bas Bloem, Parkinson Centre Nijmegan (ParC), Radboud University Medical Centre This interview was supported by an...